Skip to content

Advertisement

Open Access

High-yield production of 1,3-propanediol from glycerol by metabolically engineered Klebsiella pneumoniae

Contributed equally
Biotechnology for Biofuels201811:104

https://doi.org/10.1186/s13068-018-1100-5

Received: 27 December 2017

Accepted: 30 March 2018

Published: 9 April 2018

Abstract

Background

Glycerol is a major byproduct of the biodiesel industry and can be converted to 1,3-propanediol (1,3-PDO) by microorganisms through a two-step enzymatic reaction. The production of 1,3-PDO from glycerol using microorganisms is accompanied by formation of unwanted byproducts, including lactate and 2,3-butanediol, resulting in a low-conversion yield.

Results

Klebsiella pneumoniae was metabolically engineered to produce high-molar yield of 1,3-PDO from glycerol. First, the pathway genes for byproduct formation were deleted in K. pneumoniae. Then, glycerol assimilation pathways were eliminated and mannitol was co-fed to the medium. Finally, transcriptional regulation of the dha operon were genetically modified for enhancing 1,3-propanediol production. The batch fermentation of the engineered strain with co-feeding of a small amount of mannitol yielded 0.76 mol 1,3-PDO from 1 mol glycerol.

Conclusions

Klebsiella pneumoniae is useful microorganism for producing 1,3-PDO from glycerol. Implemented engineering in this study successfully improved 1,3-PDO production yield, which is significantly higher than those reported in previous studies.

Keywords

1, 3-PDO Klebsiella pneumoniae GlycerolByproductsGlycerol assimilation pathwayCo-substrateMannitol dha operon

Background

Biodiesel production has increased significantly over the past decade and, along with it, the production of glycerol, a byproduct of biodiesel production, has also increased. Intensive studies have been performed for adding value on glycerol [1]. Glycerol can be converted into a number of valuable products, including 1,3-propanediol (1,3-PDO), 3-hydroxypropionic acid, 2,3-butanediol (2,3-BDO), and lactate by metabolic engineering [2]. Among these, 1,3-PDO is a valuable chemical product that can be used as a solvent in the cosmetic industry and as a monomer to synthesize biopolymers. In 2012, the international demand for 1,3-PDO was 60.2 kton, and this has been expected to grow by 150% until 2019 [3]. Among the chemical and biochemical processes for 1,3-PDO production, fermentation has several advantages over chemical processes, including a requirement for moderate reaction conditions [4, 5].

Certain microorganisms, including Klebsiella, Citrobacter, Enterobacter, Bacillus, Lactobacillus, and Clostridium, are natural 1,3-PDO producers and have genes that encode enzymes for the required reactions on their chromosomes. Among the natural producers, Klebsiella pneumoniae in particular has advantages. This species grows fast on glycerol under both aerobic and anaerobic conditions, and a number of genetic modification tools have been already established. In addition, K. pneumoniae produces vitamin B12, a coenzyme of glycerol dehydratase, which is involved in synthesis of the 1,3-PDO precursor, 3-hydroxypropionaldehyde [6]. For these reasons, K. pneumoniae has often been used as a host for the biochemical production of 1,3-PDO from glycerol. 1,3-PDO production has been increased by various strategies such as preventing byproduct formation, co-producing valuable metabolites, and rebalancing reducing cofactors [710]. The titers, productivities, and yields of 1,3-PDO from glycerol achieved in recent studies are summarized in Table 1. When producing 1,3-PDO using microorganisms, many unwanted byproducts, such as lactate and 2,3-BDO, are produced. In particular, the separation of 1,3-PDO from 2,3-BDO significantly increases the overall cost of the process [11]. Therefore, generating a higher molar yield of 1,3-PDO from glycerol is highly desirable [7].
Table 1

Comparison of the recent studies for 1,3-propanediol production from glycerol using engineered Klebsiella pneumonia

Sources

Fermentation

Time (h)

Titer (g L−1)

Yield (mol mol−1 glycerol)

Productivity (g L−1 h−1)

Comments

Lin et al. [10]

30

76.80

0.66

2.56

Fed-batch

Kumar et al. [9]

36

38.95

0.49

1.08

Fed-batch with no BDO production

Wang et al. [7]

33

86.00

0.59

2.69

Fed-batch

Xin et al. [8]

30

76.20

0.43

2.54

Fed-batch

This study

24

20.59

0.76

0.86

Batch with no BDO production

In this present study, we utilized several strategies to generate a higher molar yield of 1,3-PDO from glycerol (Fig. 1). First, genes in the pathway responsible for production of unwanted byproducts were eliminated, including genes encoding lactate dehydrogenase (ldhA, Gene ID: 12545375 [Genbank]), formate acetyltransferase (pflB, Gene ID: 12544797 [Genbank]), and alpha-acetonelactate decarboxylase (budA, Gene ID: 12546009 [Genbank]) [12, 13]. Second, glycerol assimilation pathways were eliminated by deleting the genes encoding glycerol kinase (glpK, Gene ID: 12548005 [Genbank]) and glycerol dehydrogenase (dhaD, Gene ID: 12547488 [Genbank]) (Fig. 1a). The resulting strain had an improved 1,3-PDO molar yield from glycerol when a co-substrate, mannitol, was supplied for cell growth and maintenance. Finally, dha regulators were engineered for more efficient conversion of glycerol to 1,3-PDO (Fig. 1b). Negative regulators of DhaK (NCBI-Protein ID: AEJ99992) and DhaM (NCBI-Protein ID: AEJ99994) were deleted, while a positive regulator, DhaL (NCBI-Protein ID: AEJ99993), was overexpressed [14]. The resulting strain produced 1,3-PDO more rapidly during batch fermentation with a molar yield of 0.76 mol mol−1 glycerol. This yield was superior to those reported in other studies, which have reported molar yields of up to 0.66 mol mol−1 glycerol (Table 1) [10, 15, 16].
Fig. 1

Engineered metabolic pathways and regulators in this study. a Metabolic pathways of K. pneumoniae for 1,3-propanediol (1,3-PDO) production and microbial growth. Eliminated pathways in this study on byproducts formation and glycerol assimilation are presented with dashed gray arrows. Pathways with multiple steps are presented with dotted arrows. The acronyms, 3-HPA, DHA, G3P, DHAP, and TCA, refer to 3-hydroxypropionaldehyde, dihydroxyacetone, glyceraldehyde 3-phosphate, dihydroxyacetone phosphate, and tricarboxylic acid, respectively. Genes involved in those pathways are in italics. b Engineering scheme of dha operon with its regulations. PdhaK, the promoter of dhaK, is transcriptionally repressed by DhaK and DhaM and activated by DhaL. ADP forms a complex with DhaL, which binds to the sensing domain of DhaR, thus activating DhaR. ADP and DhaL complexes are inactivated by DhaM-mediated phosphorylation. DhaK inactivates DhaR by binding. Activated DhaR by ADP-DhaL complex activates dhaT expression, while represses dhaB. Black solid arrows stand for activation and gray closed arrows stand for inhibition. Black dashed arrows indicate protein modification [14]. KMK-23M, KMK-46, and KMY on the right-hand side represent the engineered strains (Table 2)

Methods

Strains, plasmids, and primers

The strains, plasmids, and primers used in this study are listed in Table 2 and Additional file 1: Table S1. All K. pneumoniae strains were derived from the wild-type strain KCTC 2242 (Korean Collection for Type Culture) [17]. KMK-01, KMK-02, and KMK-05 strains have been reported in our previous study [12]. To construct additional deletion mutants, λ red recombination was used with pRedET-transformed strains [18]. The plasmid pKD4 was used to synthesize an antibiotic-resistant gene flanked by FLP recognition target sites, while 707-FLP was used to eliminate the resistance cassette. The KMK-11, KMK-12, KMK-21, KMK-22, KMK-23, and KMK-46 strains (Table 2) were constructed using this method. Deletions of target genes were confirmed by agarose gel electrophoresis (Additional file 2: Figure S1) and sequencing their PCR products generated with genomic DNA of the strains and confirmation primers, indicated by ‘con’ in their name in Additional file 1: Table S1.
Table 2

K. pneumoniae strains and plasmids used in this study

Strain or plasmid

Description

Source

Strains

 KMK-01

KCTC 2242 ΔwabG

[12]

 KMK-02

KCTC 2242 ΔwabG ΔldhA

[12]

 KMK-05

KCTC 2242 ΔwabG ΔldhA ΔpflB

[12]

 KMK-12

KCTC 2242 ΔwabG ΔldhA ΔpflB ΔbudA

This study

 KMK-21

KCTC 2242 ΔwabG ΔldhA ΔpflB ΔbudA ΔdhaD

This study

 KMK-22

KCTC 2242 ΔwabG ΔldhA ΔpflB ΔbudA ΔglpK

This study

 KMK-23

KCTC 2242 ΔwabG ΔldhA ΔpflB ΔbudA ΔdhaD ΔglpK

This study

 KMK-23M

KMK-23 edited 5′-UTR of mtlA for reduced expression level

This study

 KMK-46

KMK-23M ΔdhaKLM

This study

 KMY

KMK-46 harboring pZS21dhaL

This study

Plasmids

 pRedET

λ phage red γ,β,α-producing vector, pBAD_promoter; ori101 Tetr

Gene bridges

 707-FLP

Flp recombinase-producing vector; Psc101 ori cI1578 Tetr

Gene bridges

 pKD4

FRT-flanked resistance cassette-involved vector; oriRγ Kmr

[16]

 pZA31::MCS

Expression vector, CmR, p15A ori

Expressys

 pZS21::MCS

Expression vector, KmR, pSC101 ori

Expressys

 pZA-Cas9

pZA31MCS, but PLtetO-1::cas9-PsacB::sacB

[23]

 pZS-CRISPR

pZS21MCS, but PLtetO-1::TracerRNA-PsacB::sacB

[23]

 pZS-CRISPR mtlA

pZS21MCS, but PLtetO-1::TracerRNA-5′UTR(mtlA)-PsacB::sacB

This study

 pZS21dhaL

pZS21::MCS harboring dhaL from wild-type K. pneumoniae

This study

 pZA31budABC

pZA31::MCS harboring budABC from wild-type K. pneumoniae

This study

Ap R ampicillin, Tet R tetracycline, Cm R chloramphenicol, Km R kanamycin resistance

Decreased mtlA (Gene ID: 12547935 [Genbank]) gene expression in KMK-23 was achieved by mutation of its 5′-untranslated region (UTR). The sequence of 5′-UTR of mtlA has been designed by RBS calculator [19, 20] to have 62% mtlA expression compared to the parental strain. The sequence 5′-TAGACAGAGTCTAACAGACCATCGAGGAACGTATG-3′, which consists of bases − 32 to − 1 from the mtlA translation start codon, was chosen and introduced to the 5′-UTR region using genome editing with CRISPR/Cas9 [21, 22]. The plasmids, pZA-Cas9 and pZS-CRISPR, for genome editing were used as reported in a previous study [23]. The DNA fragments, mtlA CRISPR F and R (Additional file 1: Table S1), were synthesized, annealed, and inserted into pZS-CRISPR at BsaI to generate crRNA. The resulting plasmid was designated pZS-CRISPR mtlA. The DNA fragments, and mtlA rescue F and R (Additional file 1: Table S1) were synthesized, annealed, and used as rescue DNA. The plasmid pZS-CRISPR mtlA and rescue DNA were transformed into a pZA-Cas9 containing KMK-23 strain. The genome-edited strain, KMK-23M, was confirmed by DNA sequencing.

The dhaL gene was cloned into the pZS21MCS plasmid using the Gibson assembly method [24, 25]. The plasmid pZS21::MCS was cut using restriction enzymes, HindIII and MluI, and assembled with amplified dhaL gene fragment generated with primers dhaL F and R (Additional file 1: Table S1) by NEBuilder Assembly Tool (http://nebuilder.neb.com). The resulting plasmid, pZS21dhaL, was transformed into KMK-46 to construct KMY. The engineered strains and plasmids were confirmed by DNA sequencing.

Media and culture conditions

In this study, the media components used in addition to the carbon sources were as follows: 3 g L−1 KH2PO4, 6.8 g L−1 Na2HPO4, 0.75 g L−1 KCl, 5.35 g L−1 (NH4)2SO4, 0.28 g L−1 Na2SO4, 0.26 g L−1 MgSO4·7H2O, 0.42 g L−1 citric acid, 10 g L−1 yeast extract, 10 g L−1 casamino acids, 1 mL of a microelement solution (0.07 g L−1 ZnCl2, 0.1 g L−1 Na2MO4·2H2O, 0.1 g L−1 MnCl2·4H2O, 0.2 g L−1 CoCl2·6H2O, 0.025 g L−1 NiCl2·7H2O, 0.02 g L−1 CuCl2·2H2O, and 0.06 g L−1 H3BO3), and 1 mL of an iron solution (10 g L−1 FeSO4·7H2O). Strains were selected on LB medium (10 g L−1 tryptone, 5 g L−1 yeast extract, and 10 g L−1 NaCl) supplemented with the appropriate antibiotics, such as 50 μg mL−1 chloramphenicol, 100 μg mL−1 kanamycin, and 20 μg mL−1 tetracycline.

To evaluate byproducts production of KMK-01, KMK-02, KMK-05, KMK-11, and KMK-12, 55 g L−1 glycerol was fed as a carbon source. For the strains, which the glycerol assimilation pathway was eliminated, 40 g L−1 glycerol was fed as a carbon source along with 20 g L−1 of mannitol, glucose, xylose, or galactose. For the KMY strain, the medium was supplemented with kanamycin (100 μg mL−1). Cultures were incubated in 30 mL volumes from 1% (v/v) inoculums in 100-mL Erlenmeyer flasks sealed with silicon stoppers under microaerobic conditions at 37 °C with shaking at 250 rpm. Batch fermentation was performed in a volume of 1 L from 5% (v/v) inoculums in a 2.5 L bioreactor (Bio Control & System, Daejeon, South Korea). The conditions for batch fermentation were 37 °C, shaking at 150 rpm, 0.4 vvm, and pH maintained between 6.5 and 7.0, where the pH was adjusted with 5 M NaOH and antifoam 204 (Sigma, St. Louis, MO, USA) was added as needed. Dissolved oxygen was monitored by D500 OxyProbe® II DO Sensor (Broadley-James Corporation, Irvine, CA, USA) during the fermentation. The cultivations were performed at least three times.

Analytical methods

The cell density was monitored by UV visibility spectrophotometer (Shimazu UV mini 1240; Shimadzu, Tokyo, Japan) at 600 nm (OD600). Culture broth (1 mL) was transferred to microcentrifuge tubes and centrifuged at 13,000 rpm for 10 min at 4 °C. Supernatants were transferred to new microcentrifuge tubes and used for analysis of metabolites. To measure concentrations of 1,3-PDO, 2,3-BDO, acetate, lactate, succinate, glycerol, mannitol, glucose, xylose, and galactose, high-performance liquid chromatography (Younglin Instrument ACME-9000, Seoul, South Korea) with a Sugar SH1011 column (Shodex, Tokyo, Japan) maintained at 70 °C, an RI detector maintained at 45 °C, and 5 mM H2SO4 as the mobile phase with a flow rate of 0.6 mL min−1 was used. NADH and NAD+ assay was conducted by NAD/NADH-GloTM Assay G9071 (Promega, Madison, WI, USA) according to the manufacturer’s protocol. Each strain for the assay was cultured to the mid-log phase (OD600 = 1) with 30 mL working volume in 100-mL Erlenmeyer flask and harvested for the assay.

Real-time RT-PCR

The strains were cultured in flask and harvested in early exponential phase (OD ~ 1). RNA was prepared by RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s protocol. Complementary DNA was synthesized by PrimeScript™ Reverse Transcriptase 2680A (Takara, Shiga, Japan). For PCR, QPCR Green Master Mix (LRox, biotechrabbit, Hennigsdorf, Germany) was used according to manufacturer’s protocol. Relative gene expression levels were measured by quantitative PCR by StepOne™ Real-Time PCR System (Applied Biosystems, Foster City, CA, USA).

Results and discussion

Pathway engineering to reduce byproduct formation

For removing pathogenicity of the strain, we deleted wabG gene from K. pneumoniae KCTC 2242, which is responsible for making a lipopolysaccharide [26]. The resulting strain, KMK-01 is a parental strain in this study. K. pneumoniae KMK-01 produces 1,3-PDO as a major product from glycerol. At the same time, it also produces a significant number of byproducts, including 2,3-BDO, lactate, acetate, and succinate (Table 3). Deletions of ldhA and pflB have been reported significantly reducing the amounts of these byproducts when glucose is fed as a carbon source [12]. When KMK-02, the KMK-01 ΔldhA mutant, was cultured in glycerol, lactate production was reduced from 0.06 to 0 mol mol−1. KMK-05, the KMK-02 ΔpflB mutant, produced no acetate, similar to previous results observed for glucose [12]. 1,3-PDO production increased from 17.94 to 20.14 g L−1 and 20.11 g L−1 in KMK-02 and KMK-05, respectively, compared to the parental strain, while the molar yield from glycerol was almost the same. Meanwhile, 2,3-BDO production increased in these mutants. Therefore, budA encoding 2,3-butanediol dehydrogenase, was deleted from the KMK-05 strain and the resulting strain was designated KMK-12. KMK-12 produced less 2,3-BDO than the parental strain, 0.04 compared to 0.23 mol mol−1, respectively. Despite the reduction in byproduct formation by KMK-12, the molar yield of 1,3-PDO from glycerol, 0.47 mol mol−1 glycerol, did not notably change (Table 3). Meanwhile, deletion of budA caused significant decreases in glycerol consumption and biomass production, resulting in a reduction in 1,3-PDO titer, as previously reported [13].
Table 3

OD600, glycerol consumption and metabolite production yields in K. pneumoniae wild type and engineered strains after 24 h of flask culturea

ldhA

 

Δ

Δ

Δ

pflB

  

Δ

Δ

budA

   

Δ

Strain name

KMK-01

KMK-02

KMK-05

KMK-12

OD600

9.66

12.18

6.47

3.65

Consumed glycerol (g L−1)

48.31

54.45

52.55

16.13

Acetate production (g L−1)

1.42

1.51

0.00

1.34

Succinate production (g L−1)

0.87

0.84

0.82

0.36

Lactate production (g L−1)

2.89

0.00

0.59

0.00

2,3-BDO production (g L−1)

6.00

6.65

11.57

0.60

1,3-PDO production (g L−1)

17.94

20.14

20.11

6.30

1,3-PDO productivity (g L−1 h−1)

0.75

0.84

0.84

0.26

1,3-PDO yield (mol mol−1)b

0.45

0.45

0.46

0.47

a Experiments were repeated three times independently

b Yield was calculated as produced metabolite (mol)/consumed glycerol (mol)

Elimination of glycerol assimilation pathways to improve 1,3-PDO yield

To improve the molar yield of 1,3-PDO from glycerol, glycerol assimilation pathways were eliminated on K. pneumoniae. Two glycerol assimilation pathways, which start from glycerol and lead into glycolysis, exist in K. pneumoniae (Fig. 1a). Glycerol kinase (GlpK, NCBI-Protein ID: AEK00501) is responsible for the conversion of glycerol to glycerol 3-phosphate, while glycerol dehydrogenase (DhaD, NCBI-Protein ID: AEJ99991) converts glycerol to dihydroxyacetone with NADH production [2729]. GlpK is active under aerobic conditions, while DhaD is active under anaerobic conditions [29]. Strains KMK-21 and 22 were constructed by deleting dhaD and glpK, respectively, from KMK-12. Strain KMK-23 was generated by deleting both dhaD and glpK from KMK-12. When these strains were cultured for 24 h in flasks containing glycerol, there were decreases in 1,3-PDO productions and molar yields in KMK-12 and KMK-23, while a marginal increase in 1,3-PDO production was in KMK-22 (Additional file 3: Table S2). It is because DhaD–DhaKLM pathway provides 1 mol of NADH for 1,3-PDO production, while GlpK–GlpD pathway does not (Fig. 1a). Therefore, dhaD deletion resulted in decreases in 1,3-PDO production, while glpK deletion did not. To prove this, NADH/NAD+ ratios were measured in KMK-12, KMK-21, KMK-22, and KMK-23 strains. The results also supported that the strains with dhaD deletion, KMK-21 and KMK-23 produced less NADH, resulting in low NADH/NAD+ ratios (Fig. 2a and b).
Fig. 2

a NADH/NAD+ ratios and b NADH and NAD+ concentrations of KMK-12, KMK-21, KMK-22 and KMK-23 strains grown in 55 g L−1 glycerol medium. c NADH/NAD+ ratios and d NADH and NAD+ concentrations of KMK-23 grown in the medium containing 40 g L−1 glycerol and 20 g L−1 various co-substrates; mannitol (Man), glucose (Glc), xylose (Xyl) and galactose (Gal)

To enhance 1,3-PDO yield, glycerol flux towards assimilation should be restricted further. Therefore, glucose was supplied as co-substrate to replace the glycolytic flux generated from glycerol assimilation. When glycerol and glucose were supplied together, the molar yield of 1,3-PDO from glycerol in KMK-21 and KMK-23 significantly increased (Table 4). Since glucose was not converted to 1,3-PDO (Additional file 4: Table S3), the molar yield of 1,3-PDO was calculated based on glycerol consumed. Deletion of dhaD (strain KMK-21) improved molar yield from 0.56 to 0.77 mol mol−1 compared to the parental strain (KMK-12). When dhaD was deleted, glycerol consumption was restricted because DhaD is active under microaerobic conditions and, therefore, this mutant assimilated very little glycerol. Deletion of glpK (KMK-22) improved 1,3-PDO production from 4.87 to 6.09 g L−1 compared to KMK-12, with a marginal improvement in yield. This may be because deletion of glpK enhances DhaD activity by more than twofold according to Ashok et al. [30]. However, it also enhances the flux into glycerol assimilation pathways, draining glycerol for energy and cell mass production. Therefore, no gain in 1,3-PDO molar yield from glycerol was observed for KMK-22. When both the glpK and dhaD genes were deleted, the molar yield of 1,3-PDO from glycerol improved from 0.56 to 0.84 mol mol−1 glycerol, with an improvement in titer from 4.87 to 5.27 g L−1. This implies that elimination of glycerol assimilation enhanced carbon flux from glycerol towards 1,3-PDO production, while energy and cell mass production were supported by flux from carbon to glucose. Compared to the previously reported molar yield of 1,3-PDO from glycerol, 0.60 mol mol−1 glycerol, [15, 16], the molar yield obtained by KMK-23 was much higher, 0.84 mol mol−1 glycerol. Despite that, we observed increased acetate production from engineered strains. Acetate production could be reduced by keeping glycerol or glucose concentration low during fed-batch fermentation [8, 31].
Table 4

Comparison of OD600, glycerol consumption, 1,3-PDO production and yield in KMK-12 and its mutants after 24 h of flask culturea

dhaD

 

Δ

 

Δ

glpK

  

Δ

Δ

Strain name

KMK-12

KMK-21

KMK-22

KMK-23

OD600

3.53

3.26

3.32

3.85

Consumed glycerol (g L−1)

10.49

7.49

13.56

7.59

Consumed glucose (g L−1)

7.80

9.24

7.15

11.97

Acetate production (g L−1)

0

2.25

1.47

1.78

Succinate production (g L−1)

0.23

0.14

0.20

0.25

1,3-PDO production (g L−1)

4.87

4.79

6.09

5.27

1,3-PDO productivity (g L−1 h−1)

0.20

0.20

0.25

0.22

1,3-PDO yield (mol mol−1)b

0.56

0.77

0.54

0.84

a Experiments were repeated three times independently

b Yield is calculated as dividing produced metabolite by consumed glycerol

Selecting a co-substrate for KMK-23

After eliminating glycerol assimilation pathways, co-substrates, i.e., glucose alternatives, were screened for efficient 1,3-PDO production. Mannitol, glucose, galactose, and xylose were tested as co-substrates with glycerol (Fig. 3). Out of the four co-substrates tested, mannitol resulted in the highest 1,3-PDO production titer, 7.84 g L−1, which is 48.7% more than that of glucose (Fig. 3). Comparing to the other three co-substrates, mannitol utilization pathway produces additionally 1 mol of NADH when mannitol-1-phosphate converts to fructose-6-phosphate [32, 33]. Indeed, NADH/NAD+ ratio was highest when mannitol was used as co-substrate (Fig. 2c, d). It is suspected that this additional NADH was beneficial to 1,3-PDO production, since 1,3-PDO production requires NADH for DhaT (NCBI-Protein ID: AEJ99987) enzymatic reaction (Fig. 2c, d).
Fig. 3

a Microbial growth (OD600), b consumption of co-substrates, c consumption of glycerol, and d 1,3-PDO production of KMK-23 in flask culture in the medium containing 40 g L−1 glycerol and 20 g L−1 four different co-substrates; mannitol (filled circle), glucose (empty circle), xylose (filled reversed triangle), and galactose (empty triangle)

However, when mannitol was used as a co-substrate, its consumption over 24 h was much higher than consumption of other co-substrates (Fig. 3). To reduce fermentation cost, mannitol consumption should be restricted. Here, we attempted to solve it by decreasing the expression level of mannitol-specific transporter, MtlA (NCBI-Protein ID: AEK00431) by genome editing [3234]. The 5′-UTR sequence of the mtlA was determined by RBS calculator and then was edited by CRISPR/Cas9 method as described in “Methods”. The resulting strain was confirmed by sequencing and designated as KMK-23M. The expression level of mtlA in KMK-23M was decreased 25% compared to KMK-23 (Additional file 5: Figure S2A). Mannitol consumption of KMK-23M until 24 h was reduced from 9.68 to 6.28 g L−1 compared to that of KMK-23, while cell mass and 1,3-PDO production both increased substantially by 31 and 34%, respectively (Fig. 4). No reduction was observed in molar yield of 1,3-PDO from glycerol. This suggests that for KMK-23, the glycolytic flux supplied by mannitol exceeded the optimal point. Therefore, reducing glycolytic flux in KMK-23M benefited both cell growth and the conversion of glycerol to 1,3-PDO.
Fig. 4

Effects of genome editing on 5′-UTR of mtlA gene for its reduced expression on carbon source consumption and metabolite productions. When three strains, KMK-01 (wild type, black bar), KMK-23 (dashed bar), and KIK-23M (genome-edited strain, gray bar), were cultured in the medium containing 40 g L−1 glycerol and 20 g L−1 mannitol, mannitol and glycerol consumption, 1,3-PDO production, microbial growth (OD600), and 1,3-PDO production per unit mannitol consumption for 24 h were compared

Engineering of transcriptional regulation of the dha operon

Figure 1b presents the arrangement of the dha genes in the K. pneumoniae genome. The genes encoding the enzymes are directly involved in 1,3-PDO production, dhaB (Gene ID: 12547480 [Genbank]) and dhaT (Gene ID: 12547484 [Genbank]), which belong to the dha operon [14]. According to a study by Bächler et al. [35], the promoter of the dhaKLM operon in Escherichia coli, PdhaK, is negatively regulated by DhaK and DhaM, and positively regulated by DhaL. Dephosphorylated DhaL can bind the sensing domain of DhaR (NCBI-Protein ID: AEJ99990) and activate DhaR. DhaR positively regulates dhaT expression, but negatively regulates dhaB [36]. Negative regulation of dhaB could be beneficial to 1,3-PDO production because the product of DhaB, 3-hydroxypropionaldehyde, is a toxic intermediate [37]. DhaR is repressed by DhaK, while activated by dephosphorylated DhaL that is inactivated by DhaM-mediated phosphorylation [35, 38]. In other words, dhaK and dhaM negatively regulate and dhaL positively regulates dhaT expression via DhaR.

We deleted dhaKLM on KMK-23M strain genome and named the resulting strain KMK-46. Then, the dhaL gene-encoding activator was overexpressed and the resulting strain was designated KMY, expecting DhaR activated by DhaL transcriptionally upregulates dhaT expression (Fig. 1b). To demonstrate the expression level changes of dhaR, dhaL and dhaT quantitative RT-PCR was conducted in KMK-23M, KMK-46, and KMY strains. The expression levels of dhaR were not changed significantly in those engineered strain (Fig. 5a). On the other hand, dhaL expression levels confirmed that dhaKLM deletion and dhaL overexpression were properly conducted in KMK-46 and KMY strains (Fig. 5b). As expected, dhaT expression in KMY was increased threefold than KMK-23M and KMK-46 (Fig. 5c). Interestingly, KMK-46, dhaKLM deleted strain, did not produce 1,3-PDO at all, while dhaL overexpression in that strain increased 1,3-PDO production by 26.4% compared to KMK-23M (Fig. 6a–d). The molar yield of KMY was also 20% higher than for KMK-23M (Fig. 6e). This is contrast to the result of overexpression of dhaR (Additional file 5: Figure S2B) in the KMK-46 strain, resulted in no 1,3-PDO production (data not shown). In addition, when dhaT was overexpressed in KMK-23M and KMK-46 strains, 1,3-PDO production was much less than that of KMY (data not shown). These results suggest that the regulation of dha operon is not simple and has not been fully understood yet. In this study, the developed KMY strain with deletion of dhaKLM and overexpression of dhaL partially proved their regulatory functions on dhaT expression.
Fig. 5

Relative expression levels of a dhaR, b dhaL and c dhaT in KMK-23M, KMK-46 and KMY strains detected by real-time RT-PCR. The expression levels of KMK-46 and KMY were normalized with cell mass (OD600) and with the ones of control strain, KMK-23M. The expression levels were measured three times with the strains grown in 40 g L−1 glycerol and 20 g L−1 mannitol up to mid-log phase and the error bars represented the standard deviations

Fig. 6

a Microbial growth (OD600), b mannitol, c glycerol, and d 1,3-PDO concentrations of KMK-23M (filled circle), KMK-46 (empty circle), and KMY (filled reversed triangle) strains in flask culture. e Comparison of 1,3-PDO production (g L−1) and its molar yield (mol mol−1 glycerol) between KMK-23M and KMY strains during 24 h. Bars represent titer and diamond-shaped dot represent yields. f Batch fermentation results of KMY strain with the concentrations of mannitol (filled circle) and glycerol (empty circle), 1,3-PDO (filled reversed triangle), and OD600 (empty triangle)

Batch fermentation was performed with the resulting strain, KMY. A total of 20.59 g L−1 1,3-PDO was produced in 24 h with a molar yield of 0.76 mol mol−1 glycerol (Fig. 6f). The 1,3-PDO yield from the carbon sources in total, including mannitol, was 0.54 g g−1. The molar yield in this study was superior to that reported in other published studies; these studies reported molar yields of around 0.6 mol mol−1 glycerol [15, 16]. The increase in the 1,3-PDO titer from batch fermentation compared to culturing in flasks may be due to the pH control during the process. During the entire fermentation, dissolved oxygen level was maintained at near zero percent, because the microaerobic condition with low aeration has been known to be beneficial for 1,3-PDO production [5]. The developed strain produced significantly lower amounts of byproducts with a much higher molar yield of 1,3-PDO from glycerol. This could be extremely helpful in reducing the cost of product separation [11]. The high-molar yield of 1,3-PDO was enabled by eliminating genes in the glycerol assimilation pathway and feeding bacteria a co-substrate for cell mass and maintenance energy. Regulators influencing expression of dhaT were also helpful in increasing 1,3-PDO production and yield compared to the parental strain. With continuous metabolic engineering, a cost-effective biochemical process to produce 1,3-PDO using K. pneumoniae would be possible near future.

Conclusions

In this study, we minimized the production of byproducts during 1,3-PDO synthesis by deleting the pathway genes from the K. pneumoniae genome. Next, the glycerol assimilation pathway was eliminated and mannitol was fed as a co-substrate to improve glycerol flux towards 1,3-PDO production. The 5′-UTR of mtlA was edited to reduce mannitol consumption. Finally, 1,3-PDO production was enhanced by modifying dha regulation through deletion of dhaKLM and overexpression of dhaL. In batch fermentation, 1,3-PDO was produced with the yield of 0.76 mol mol−1 glycerol. The molar yield in this study was superior to previously published studies.

Notes

Abbreviations

1,3-PDO: 

1,3-propanediol

2,3-BDO: 

2,3-butanediol

BudA: 

alpha-acetonelactate decarboxylase

DhaB: 

glycerol dehydratase

DhaD: 

glycerol dehydrogenase

DhaK: 

dihydroxyacetone kinase subunit K

DhaL: 

dihydroxyacetone kinase subunit L

DhaM: 

dihydroxyacetone kinase subunit M

DhaR: 

DNA-binding transcriptional regulator of dha operon

DhaT: 

1,3-PDO dehydrogenase

GlpK: 

glycerol kinase

LdhA: 

lactate dehydrogenase

MtlA: 

mannitol-specific transporter

PdhaK: 

dhaK promoter

PflB: 

formate acetyltransferase

Declarations

Authors’ contributions

The study was designed by MKO and MYJ. JHL and MYJ performed the experiments and analyzed the results together with MKO. The manuscript was drafted by JHL with contributions from all authors. All authors read and approved the final manuscript.

Acknowledgements

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable requests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Funding

This study was supported by a grant from the New & Renewable Energy Program of the Korea Institute of Energy Technology Evaluation and Planning (No. 20143030091040); and a grant from the National Research Foundation of Korea funded by the Korean Government (2012M1A2A2026560 and 2015M3D3A1A01064919).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Chemical and Biological Engineering, Korea University, Seoul, Republic of Korea
(2)
CJ Research Institute of Biotechnology, Suwon, Republic of Korea

References

  1. Yang F, Hanna MA, Sun R. Value-added uses for crude glycerol—a by-product of biodiesel production. Biotechnol Biofuels. 2012;5:3.View ArticleGoogle Scholar
  2. da Silva GP, Mack M, Contiero J. Glycerol: a promising and abundant carbon source for industrial microbiology. Biotechnol Adv. 2009;27:20–39.View ArticleGoogle Scholar
  3. Lee CS, Aroua MK, Daud WAW, Cognet P, Peres-Lucchese Y, Fabre PL, Reynes O, Latapie L. A review: conversion of bioglycerol into 1,3-propanediol via biological and chemical method. Renew Sustain Energy Rev. 2015;42:963–72.View ArticleGoogle Scholar
  4. Anand P, Saxena RK, Marwah RG. A novel downstream process for 1,3-propanediol from glycerol-based fermentation. Appl Microbiol Biotechnol. 2011;90:1267–76.View ArticleGoogle Scholar
  5. Saxena RK, Pinki A, Saurabh S, Jasmine I. Microbial production of 1,3-propanediol: recent developments and emerging opportunities. Biotechnol Adv. 2009;27:895–913.View ArticleGoogle Scholar
  6. Kumar V, Park S. Potential and limitations of Klebsiella pneumoniae as a microbial cell factory utilizing glycerol as the carbon source. Biotechnol Adv. 2017;36:150–67.View ArticleGoogle Scholar
  7. Wang M, Wang G, Zhang T, Fan L, Tan T. Multi-modular engineering of 1,3-propanediol biosynthesis system in Klebsiella pneumoniae from co-substrate. Appl Microbiol Biotechnol. 2017;101:647–57.View ArticleGoogle Scholar
  8. Xin B, Tao F, Wang Y, Liu H, Ma C, Xu P. Coordination of metabolic pathways: enhanced carbon conservation in 1,3-propanediol production by coupling with optically pure lactate biosynthesis. Metab Eng. 2017;41:102–14.View ArticleGoogle Scholar
  9. Kumar V, Durgapal M, Sankaranarayanan M, Somasundar A, Rathnasigh C, Song H, Seung D, Park S. Effects of mutation of 2,3-butanediol formation pathway on glycerol metabolism and 1,3-propanediol production by Klebsiella pneumoniae J2B. Bioresour Technol. 2016;214:432–40.View ArticleGoogle Scholar
  10. Lin J, Zhang Y, Xu D, Xiang G, Jia Z, Fu S, Gong H. Deletion of poxB, pta, and ackA improves 1,3-propanediol production by Klebsiella pneumoniae. Appl Microbiol Biotechnol. 2016;100:2775–84.View ArticleGoogle Scholar
  11. Xiu ZL, Zeng AP. Present state and perspective of downstream processing of biologically produced 1,3-propanediol and 2,3-butanediol. Appl Microbiol Biotechnol. 2008;78:917–26.View ArticleGoogle Scholar
  12. Jung MY, Mazumdar S, Shin HS, Yang KS, Lee J, Oh MK. Improvement of 2,3-butanediol yield in Klebsiella pneumonia by deletion of the pyruvate formate-lyase gene. Appl Environ Microbiol. 2014;80:6195–203.View ArticleGoogle Scholar
  13. Zhang G, Yang G, Wang X, Guo Q, Li J. Influence of blocking of 2,3-butanediol pathway on glycerol metabolism for 1,3-propanediol production by Klebsiella oxytoca. Appl Biochem Biotechnol. 2012;168:116–28.View ArticleGoogle Scholar
  14. Sun J, Heuvel J, Soucaille P, Qu Y, Zeng A. Comparative genomic analysis of dha regulon and related genes for anaerobic glycerol metabolism in bacteria. Biotechnol Prog. 2003;19:263–72.View ArticleGoogle Scholar
  15. Huang J, Wu Y, Wu W, Liu D, Chen Z. Cofactor recycling for co-production of 1,3-propanediol and glutamate by metabolically engineered Corynebacterium glutamicum. Sci Rep. 2017;7:42246.View ArticleGoogle Scholar
  16. Kaur G, Srivastava AK, Chand S. Advances in biotechnological production of 1,3-propanediol. Biochem Eng J. 2012;64:106–18.View ArticleGoogle Scholar
  17. Shin SH, Kim S, Kim JY, Lee S, Um Y, Oh MK, Kim YR, Lee J, Yang KS. Complete genome sequence of the 2,3-butanediol-producing Klebsiella pneumoniae strain KCTC 2242. J Bacteriol. 2012;194:2736–7.View ArticleGoogle Scholar
  18. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA. 2000;97:6640–5.View ArticleGoogle Scholar
  19. Borujeni AE, Channarasappa AS, Salis HM. Translation rate is controlled by coupled trade-offs between site accessibility, selective RNA unfolding and sliding at upstream standby sites. Nucleic Acids Res. 2013;42:2646–59.View ArticleGoogle Scholar
  20. Salis HM, Mirsky EA, Voigt CA. Automated design of synthetic ribosome binding sites to control protein expression. Nat Biotechnol. 2009;27:946–52.View ArticleGoogle Scholar
  21. Jiang WY, Bikard D, Cox D, Zhang F, Marraffini LA. RNA-guided editing of bacterial genomes using CRISPR–Cas systems. Nat Biotechnol. 2013;31:233–9.View ArticleGoogle Scholar
  22. Qi LS, Larson MH, Gilbert L, Doudna JA, Weissman JS, Arkin AP, Lim WA. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell. 2013;152:1173–83.View ArticleGoogle Scholar
  23. Heo MJ, Jung HM, Um J, Lee SW, Oh MK. Controlling citrate synthase expression by CRISPR/Cas9 genome editing for n-butanol production in Escherichia coli. ACS Synth Biol. 2017;6:182–9.View ArticleGoogle Scholar
  24. Gibson DG, Glass JI, Lartique C, Noskov VN, Chuang RY, Algire MA, Benders GA, Montague MG, Ma L, Moodie MM, Merryman C, Bashee S, Krishnakumar R, Assad-Garcia N, Andrews-Pfannkoch C, Denisova EA, Young L, Qi ZQ, Seqall-Shapiro TH, Calvey CH, Hutchison CA 3rd, Smith HO, Venter JC. Creation of a bacterial cell controlled by a chemically synthesized genome. Science. 2010;329:52–6.View ArticleGoogle Scholar
  25. Gibson DG, Young L, Chuang RY, Venter JC, Hutchison CA 3rd, Smith HO. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods. 2009;6:343–5.View ArticleGoogle Scholar
  26. Izquierdo L, Coderch N, Pique N, Bedini E, Corsaro MM, Frensno S, Tomas JM, Reque M. The Klebsiella pneumoniae wabG gene: role in biosynthesis of the core lipopolysaccharide and virulence. J Bacteriol. 2003;185:7213–21.View ArticleGoogle Scholar
  27. Celińska E. Debottlenecking the 1,3-propanediol pathway by metabolic engineering. Biotechnol Adv. 2010;28:519–30.View ArticleGoogle Scholar
  28. Johnson EA, Lin EC. Klebsiella pneumoniae 1,3-propanediol: NAD+ oxidoreductase. J Bacteriol. 1987;169:2050–4.View ArticleGoogle Scholar
  29. Forage RG, Lin EC. DHA system mediating aerobic and anaerobic dissimilation of glycerol in Klebsiella pneumoniae NCIB 418. J Bacteriol. 1982;151:591–9.Google Scholar
  30. Ashok S, Raj SM, Ko Y, Sankaranarayanan M, Zhou S, Kumar V, Park S. Effect of puuC overexpression and nitrate addition on glycerol metabolism and anaerobic 3-hydroxypropionic acid production in recombinant Klebsiella pneumoniae ΔglpKΔdhaT. Metab Eng. 2013;15:10–24.View ArticleGoogle Scholar
  31. De Mey M, De Maeseneire S, Soetaert W, Vandamme E. Minimizing acetate formation in E. coli fermentations. J Ind Microbiol Biotechnol. 2007;34:689–700.View ArticleGoogle Scholar
  32. Otte S, Lengeler JW. The mtl genes and the mannitol-1-phosphate dehydrogenase from Klebsiella pneumoniae KAY2026. FEMS Microbiol Lett. 2001;194:221–7.View ArticleGoogle Scholar
  33. Honeyman AL, Curtiss R 3rd. The mannitol-specific enzyme II (mtlA) gene and the mtlR gene of the PTS of Streptococcus mutants. Microbiology. 2000;146:1565–72.View ArticleGoogle Scholar
  34. Rudd KE. EcoGene: a genome sequence database for Escherichia coli K-12. Nucleic Acids Res. 2000;28:60–4.View ArticleGoogle Scholar
  35. Bächler C, Schneider P, Bächler P, Lustig A, Erni B. Escherichia coli dihydroxyacetone kinase controls gene expression by binding to transcription factor DhaR. EMBO J. 2005;24:283–93.View ArticleGoogle Scholar
  36. Zheng P, Wereath K, Sun J, Van den Heuvel J, Zeng AP. Overexpression of genes of the dha regulon and its effects on cell growth, glycerol fermentation to 1,3-propanediol and plasmid stability in Klebsiella pneumoniae. Process Biochem. 2006;41:2160–9.View ArticleGoogle Scholar
  37. Barbirato F, Grivet JP, Soucaille P, Bories A. 3-Hydroxypropionaldehyde, an inhibitory metabolite of glycerol fermentation to 1,3-propanediol by enterobacterial species. Appl Environ Microbiol. 1996;62:1448–51.Google Scholar
  38. Deutscher J, Francke C, Postma PW. How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria. Microbiol Mol Biol Rev. 2006;70:939–1031.View ArticleGoogle Scholar

Copyright

© The Author(s) 2018

Advertisement